United States Imitrex Market Report 2016

Publisher Name :
Date: 19-Sep-2016
No. of pages: 122
Inquire Before Buying

Notes:

Sales, means the sales volume of Imitrex

Revenue, means the sales value of Imitrex

This report studies sales (consumption) of Imitrex in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

- Pfizer, Inc. (USA)

- Bayer Consumer Care (USA)

- Aegis Therapeutics LLC (USA)

- Alza Corporation (USA)

- AptarGroup, Inc. (USA)

- Archimedes Pharma Limited. (UK)

- AstraZeneca Plc. (UK)

- MedImmune, Inc. (USA)

- Bespak Plc. (UK)

- GlaxoSmithKline Plc. (UK)

- Ikano Therapeutics Inc. (USA)

- Javelin Pharmaceuticals, Inc. (USA)

- Kurve Technology, Inc. (USA)

- Marina Biotech, Inc. (USA)

- Merck & Co., Inc. (USA)

- Novartis AG (Switzerland)

- OptiNose AS (Norway)

- Rexam Plc. (UK)

- Sanofi S.A. (France)

- Unigene Laboratories, Inc. (USA)

Split by product Types, with sales, revenue, price, market share and growth rate of each type, can be divided into

- Type I

- Type II

- Type III

Split by applications, this report focuses on sales, market share and growth rate of Imitrex in each application, can be divided into

- Application 1

- Application 2

- Application 3

United States Imitrex Market Report 2016

Table of Contents
United States Imitrex Market Report 2016
1 Imitrex Overview
1.1 Product Overview and Scope of Imitrex
1.2 Classification of Imitrex
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Application of Imitrex
1.3.1 Application 1
1.3.2 Application 2
1.3.3 Application 3
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Imitrex (2011-2021)
1.4.1 USA Imitrex Sales and Growth Rate (2011-2021)
1.4.2 USA Imitrex Revenue and Growth Rate (2011-2021)
2 USA Imitrex Competition by Manufacturers
2.1 USA Imitrex Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Imitrex Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Imitrex Average Price by Manufactures (2015 and 2016)
2.4 Imitrex Market Competitive Situation and Trends
2.4.1 Imitrex Market Concentration Rate
2.4.2 Imitrex Market Share of Top 3 and Top 5 Manufacturers
2.4.3 Mergers & Acquisitions, Expansion
3 USA Imitrex Sales (Volume) and Revenue (Value) by Type (2011-2016)
3.1 USA Imitrex Sales and Market Share by Type (2011-2016)
3.2 USA Imitrex Revenue and Market Share by Type (2011-2016)
3.3 USA Imitrex Price by Type (2011-2016)
3.4 USA Imitrex Sales Growth Rate by Type (2011-2016)
4 USA Imitrex Sales (Volume) by Application (2011-2016)
4.1 USA Imitrex Sales and Market Share by Application (2011-2016)
4.2 USA Imitrex Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities
5 USA Imitrex Manufacturers Profiles/Analysis
5.1 Pfizer, Inc. (USA)
5.1.1 Company Basic Information, Manufacturing Base and Competitors
5.1.2 Imitrex Product Type, Application and Specification
5.1.2.1 Type I
5.1.2.2 Type II
5.1.3 Pfizer, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.1.4 Main Business/Business Overview
5.2 Bayer Consumer Care (USA)
5.2.2 Imitrex Product Type, Application and Specification
5.2.2.1 Type I
5.2.2.2 Type II
5.2.3 Bayer Consumer Care (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.2.4 Main Business/Business Overview
5.3 Aegis Therapeutics LLC (USA)
5.3.2 Imitrex Product Type, Application and Specification
5.3.2.1 Type I
5.3.2.2 Type II
5.3.3 Aegis Therapeutics LLC (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.3.4 Main Business/Business Overview
5.4 Alza Corporation (USA)
5.4.2 Imitrex Product Type, Application and Specification
5.4.2.1 Type I
5.4.2.2 Type II
5.4.3 Alza Corporation (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.4.4 Main Business/Business Overview
5.5 AptarGroup, Inc. (USA)
5.5.2 Imitrex Product Type, Application and Specification
5.5.2.1 Type I
5.5.2.2 Type II
5.5.3 AptarGroup, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.5.4 Main Business/Business Overview
5.6 Archimedes Pharma Limited. (UK)
5.6.2 Imitrex Product Type, Application and Specification
5.6.2.1 Type I
5.6.2.2 Type II
5.6.3 Archimedes Pharma Limited. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.6.4 Main Business/Business Overview
5.7 AstraZeneca Plc. (UK)
5.7.2 Imitrex Product Type, Application and Specification
5.7.2.1 Type I
5.7.2.2 Type II
5.7.3 AstraZeneca Plc. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.7.4 Main Business/Business Overview
5.8 MedImmune, Inc. (USA)
5.8.2 Imitrex Product Type, Application and Specification
5.8.2.1 Type I
5.8.2.2 Type II
5.8.3 MedImmune, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.8.4 Main Business/Business Overview
5.9 Bespak Plc. (UK)
5.9.2 Imitrex Product Type, Application and Specification
5.9.2.1 Type I
5.9.2.2 Type II
5.9.3 Bespak Plc. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.9.4 Main Business/Business Overview
5.10 GlaxoSmithKline Plc. (UK)
5.10.2 Imitrex Product Type, Application and Specification
5.10.2.1 Type I
5.10.2.2 Type II
5.10.3 GlaxoSmithKline Plc. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
5.10.4 Main Business/Business Overview
5.11 Ikano Therapeutics Inc. (USA)
5.12 Javelin Pharmaceuticals, Inc. (USA)
5.13 Kurve Technology, Inc. (USA)
5.14 Marina Biotech, Inc. (USA)
5.15 Merck & Co., Inc. (USA)
5.16 Novartis AG (Switzerland)
5.17 OptiNose AS (Norway)
5.18 Rexam Plc. (UK)
5.19 Sanofi S.A. (France)
5.20 Unigene Laboratories, Inc. (USA)
6 Imitrex Manufacturing Cost Analysis
6.1 Imitrex Key Raw Materials Analysis
6.1.1 Key Raw Materials
6.1.2 Price Trend of Key Raw Materials
6.1.3 Key Suppliers of Raw Materials
6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
6.2.1 Raw Materials
6.2.2 Labor Cost
6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Imitrex
7 Industrial Chain, Sourcing Strategy and Downstream Buyers
7.1 Imitrex Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Imitrex Major Manufacturers in 2015
7.4 Downstream Buyers
8 Marketing Strategy Analysis, Distributors/Traders
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
8.2.1 Pricing Strategy
8.2.2 Brand Strategy
8.2.3 Target Client
8.3 Distributors/Traders List
9 Market Effect Factors Analysis
9.1 Technology Progress/Risk
9.1.1 Substitutes Threat
9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change
10 USA Imitrex Market Forecast (2016-2021)
10.1 USA Imitrex Sales, Revenue Forecast (2016-2021)
10.2 USA Imitrex Sales Forecast by Type (2016-2021)
10.3 USA Imitrex Sales Forecast by Application (2016-2021)
10.4 Imitrex Price Forecast (2016-2021)
11 Research Findings and Conclusion
12 Appendix
Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer
List of Tables and Figures
Figure Picture of Imitrex
Table Classification of Imitrex
Figure USA Sales Market Share of Imitrex by Type in 2015
Table Application of Imitrex
Figure USA Sales Market Share of Imitrex by Application in 2015
Figure USA Imitrex Sales and Growth Rate (2011-2021)
Figure USA Imitrex Revenue and Growth Rate (2011-2021)
Table USA Imitrex Sales of Key Manufacturers (2015 and 2016)
Table USA Imitrex Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Imitrex Sales Share by Manufacturers
Figure 2016 Imitrex Sales Share by Manufacturers
Table USA Imitrex Revenue by Manufacturers (2015 and 2016)
Table USA Imitrex Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Imitrex Revenue Share by Manufacturers
Table 2016 USA Imitrex Revenue Share by Manufacturers
Table USA Market Imitrex Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Imitrex Average Price of Key Manufacturers in 2015
Figure Imitrex Market Share of Top 3 Manufacturers
Figure Imitrex Market Share of Top 5 Manufacturers
Table USA Imitrex Sales by Type (2011-2016)
Table USA Imitrex Sales Share by Type (2011-2016)
Figure USA Imitrex Sales Market Share by Type in 2015
Table USA Imitrex Revenue and Market Share by Type (2011-2016)
Table USA Imitrex Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Imitrex by Type (2011-2016)
Table USA Imitrex Price by Type (2011-2016)
Figure USA Imitrex Sales Growth Rate by Type (2011-2016)
Table USA Imitrex Sales by Application (2011-2016)
Table USA Imitrex Sales Market Share by Application (2011-2016)
Figure USA Imitrex Sales Market Share by Application in 2015
Table USA Imitrex Sales Growth Rate by Application (2011-2016)
Figure USA Imitrex Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (USA) Basic Information List
Table Pfizer, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Bayer Consumer Care (USA) Basic Information List
Table Bayer Consumer Care (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Consumer Care (USA) Imitrex Sales Market Share (2011-2016)
Table Aegis Therapeutics LLC (USA) Basic Information List
Table Aegis Therapeutics LLC (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aegis Therapeutics LLC (USA) Imitrex Sales Market Share (2011-2016)
Table Alza Corporation (USA) Basic Information List
Table Alza Corporation (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alza Corporation (USA) Imitrex Sales Market Share (2011-2016)
Table AptarGroup, Inc. (USA) Basic Information List
Table AptarGroup, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table AptarGroup, Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Archimedes Pharma Limited. (UK) Basic Information List
Table Archimedes Pharma Limited. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Archimedes Pharma Limited. (UK) Imitrex Sales Market Share (2011-2016)
Table AstraZeneca Plc. (UK) Basic Information List
Table AstraZeneca Plc. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table AstraZeneca Plc. (UK) Imitrex Sales Market Share (2011-2016)
Table MedImmune, Inc. (USA) Basic Information List
Table MedImmune, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table MedImmune, Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Bespak Plc. (UK) Basic Information List
Table Bespak Plc. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bespak Plc. (UK) Imitrex Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Imitrex Sales Market Share (2011-2016)
Table Ikano Therapeutics Inc. (USA) Basic Information List
Table Ikano Therapeutics Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Ikano Therapeutics Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Javelin Pharmaceuticals, Inc. (USA) Basic Information List
Table Javelin Pharmaceuticals, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Javelin Pharmaceuticals, Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Kurve Technology, Inc. (USA) Basic Information List
Table Kurve Technology, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kurve Technology, Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Marina Biotech, Inc. (USA) Basic Information List
Table Marina Biotech, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marina Biotech, Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Merck & Co., Inc. (USA) Basic Information List
Table Merck & Co., Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck & Co., Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis AG (Switzerland) Imitrex Sales Market Share (2011-2016)
Table OptiNose AS (Norway) Basic Information List
Table OptiNose AS (Norway) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table OptiNose AS (Norway) Imitrex Sales Market Share (2011-2016)
Table Rexam Plc. (UK) Basic Information List
Table Rexam Plc. (UK) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Rexam Plc. (UK) Imitrex Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Imitrex Sales Market Share (2011-2016)
Table Unigene Laboratories, Inc. (USA) Basic Information List
Table Unigene Laboratories, Inc. (USA) Imitrex Sales, Revenue, Price and Gross Margin (2011-2016)
Table Unigene Laboratories, Inc. (USA) Imitrex Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Imitrex
Figure Manufacturing Process Analysis of Imitrex
Figure Imitrex Industrial Chain Analysis
Table Raw Materials Sources of Imitrex Major Manufacturers in 2015
Table Major Buyers of Imitrex
Table Distributors/Traders List
Figure USA Imitrex Production and Growth Rate Forecast (2016-2021)
Figure USA Imitrex Revenue and Growth Rate Forecast (2016-2021)
Table USA Imitrex Production Forecast by Type (2016-2021)
Table USA Imitrex Consumption Forecast by Application (2016-2021)
  • Global Active Pharmaceutical Ingredient Market by Manufacturers, Regions, Type and Application, Forecast to 2021
    Published: 05-Dec-2016        Price: US 3480 Onwards        Pages: 112
    Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. API also refers to the active or central ingredient in the product which causes the direct effect on the disease diagnosis, prevention, treatment or cure. While API is the active c......
  • Global Epilepsy Drugs Sales Market Report 2016
    Published: 05-Dec-2016        Price: US 4000 Onwards        Pages: 106
    Notes: Sales, means the sales volume of Epilepsy Drugs Revenue, means the sales value of Epilepsy Drugs This report studies sales (consumption) of Epilepsy Drugs in Global market, especially in United States, China, Europe, Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - GlaxoSmithKline - Pfizer - UCB - Eisai - Roche - Shire......
  • Europe Ganciclovir Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 102
    Notes: Sales, means the sales volume of Ganciclovir Revenue, means the sales value of Ganciclovir This report studies sales (consumption) of Ganciclovir in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Roche - Bausch & Lomb - Fresenius Kabi - Luitpold - Huatai Pha......
  • Europe Typhoid Vaccine Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 108
    Notes: Sales, means the sales volume of Typhoid Vaccine Revenue, means the sales value of Typhoid Vaccine This report studies sales (consumption) of Typhoid Vaccine in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Bharat Biotech Int. Ltd. (BBIL) - Bio-Med Pvt. Ltd. - PT BioFarm......
  • Europe Trastuzumab Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Trastuzumab Revenue, means the sales value of Trastuzumab This report studies sales (consumption) of Trastuzumab in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Bristol-Myers Squibb - Eli Lilly and Company - Merck & Co. - Roche......
  • Europe Thromboxane A2 Receptor Antagonist Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Thromboxane A2 Receptor Antagonist Revenue, means the sales value of Thromboxane A2 Receptor Antagonist This report studies sales (consumption) of Thromboxane A2 Receptor Antagonist in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Merck & Co. - ......
  • Europe Salagen Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 101
    Notes: Sales, means the sales volume of Salagen Revenue, means the sales value of Salagen This report studies sales (consumption) of Salagen in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Decartis AG - AstraZeneca PLC - Akorn, Inc. - Genexine - ......
  • Europe Rituxan Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Rituxan Revenue, means the sales value of Rituxan This report studies sales (consumption) of Rituxan in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Novartis AG - Fujifilm Kyowa Kirin Biologics - AstraZeneca PLC - Marsala Biotech......
  • Europe Prednisolone Market Report 2016
    Published: 05-Dec-2016        Price: US 3900 Onwards        Pages: 105
    Notes: Sales, means the sales volume of Prednisolone Revenue, means the sales value of Prednisolone This report studies sales (consumption) of Prednisolone in Europe market, especially in Germany, UK, France, Russia, Italy, Benelux and Spain, focuses on top players in these countries, with sales, price, revenue and market share for each player in these Countries, covering - Pfizer - Merck - Allergan - The Medicines Company - Therava......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs